Hepcinat Plus
In stock
Description
Hepcinat Plus is a prescription antiviral medication containing Sofosbuvir (400 mg) and Daclatasvir (60 mg). Manufactured by Natco Pharma, it treats chronic Hepatitis C (HCV) infections by preventing the virus from replicating in the body.
Specifications
| Main Ingredients | Sofosbuvir 400 mg & Daclatasvir 60 mg |
|---|---|
| Dosage Form | Oral Film-Coated Tablet |
| Drug Class | Direct-Acting Antiviral (DAA) |
| Primary Indication | Chronic Hepatitis C (HCV) Infection |
| Strength | 400 & 60 mg |
| Mechanism of Action | NS5B Polymerase Inhibitor + NS5A Inhibitor |
